Management

More documents

Recommendations

Info

Schie, R.M.F. van, Wadelius, M., Kamali, F., Daly, A.K., Manolopoulos,V.G., Boer, A. de, Barallon, R., Verhoef, T.I., Kirchheiner, J., HaschkeBecher, M., Briz, M., Rosendaal, F.R., Redekop, W.K., Pirmohamed, M. &Maitland - van der Zee, A.H. (2009). Genotype-guided dosing ofcoumarin derivatives: the European pharmacogenetics ofanticoagulant therapy (EU-PACT) trial design. Pharmacoeconomics,10(10), 1287-1295.Smit, F., Willemse, G., Meulenbeek, P., Koopmanschap, M.A., Balkom,A.J.L.M. van, Spinhoven, Ph. & Cuijpers, P. (2009). Cost Effectivenessand Resource Allocation. Preventing panic disorder: cost-effectivenessanalysis alongside a pragmatic randomised trial. BioMed Central, 7(8),1-12.Staring, A.B.P., Gaag, M. van der, Koopmans, G.T., Selten, J.P., Beveren,J.M. van, Hengeveld, M.W., Loonen, A.J.M. & Mulder, C.L. (2010).Treatment adherence therapy in people with psychotic disorders:randomised controlled trial. British Journal of Psychiatry, 197, 448-455.Stolk, E.A., Bont, A.A. de, Halteren, A.R., Bijlmer, R.J. & Poley, M.J.(2009). Role of health technology assessment in shaping the benefitspackage in The Netherlands. Expert review of pharmacoeconomics &outcomes research, 9(1), 85-94.Stolk, E.A., Oppe, M., Scalone, L. & Krabbe, P.F.M. (2010). DiscreteChoice Modeling for the Quantification of Health States: The Case ofthe EQ-5D. Value in Health, 13(8), 1005-1013.Tan, S.S., Oppe, M., Zoet-Nugteren, S.K., Niezen, R.A., Kofflard, M.J.M.,Cate, F.J. ten & Hakkaart van Roijen, L. (2009). A microcosting study ofdiagnostic tests for the detection of coronary artery disease in theNetherlands. European Journal of Radiology, 72(1), 98-103.Tan, S.S., Ineveld, B.M. van, Redekop, W.K. & Hakkaart van Roijen, L.(2009). Comparing Methodologies for the Allocation of Overhead andCapital Costs to Hospital Services. Value in Health, 12(4), 530-535.Tan, S.S., Rutten, F.F.H., Ineveld, B.M. van, Redekop, W.K. & Hakkaartvan Roijen, L. (2009). Comparing methodologies for the costestimation of hospital services. European Journal of Health Economics(HEPAC), 10, 39-45.Tan, S.S., Linschoten, R. van, Middelkoop, M. van, Koes, B.W., Bierma-Zeinstra, S.M.A. & Koopmanschap, M.A. (2010). Cost-utility of exercisetherapy in adolescents and young adults suffering from thepatellofemoral pain syndrome. Scandinavian Journal of Medicine &Science in Sports, 20(4), 568-579.Tan, S.S., Gils, C.W.M. van, Franken, M.G., Hakkaart-van Roijen, L. &Uyl - de Groot, C.A. (2010). The Unit Costs of Inpatient Hospital Days,Outpatient Visits and Daycare Treatments in the Fields of Oncologyand Hematology. Value in Health, 13(6), 712-719.Tilling, C.J., Krol, H.M., Tsuchiya, A., Brazier, J. & Brouwer, W.B.F.(2010). In or Out? Income Losses in Health State Valuations: A Review.Value in Health, 13(2), 298-305.80
Tromp, M., Eijsden, M. van, Ravelli, A.C.J. & Bonsel, G.J. (2009).Anonymous non-respinse analysis in the ABCD cohort study enabled byprobabilistic record linkage. Paediatric and Perinatal Epidemiology, 23,264-272.Tromp, M., Eskes, M, Reitsma, J.B., Erwich, J.J.H.M., Brouwers, H.A.A.,Rijninks, G.C., Bonsel, G.J. & Ravelli, A.C.J. (2009). Regional perinatalmortality differences in the Netherlands; care is the question. BMCPublic Health, 9(102), 1-9.Uiters, E., Deville, W., Foets, M.M.E., Spreeuwenberg, P.M. &Groenewegen, P.P. (2009). Differences between immigrant and nonimmigrantgroups in the use of primay medical care; a systematicreview. BMC Health Services Research, 9(76), 1-10.Utens, C.M.A., Goossens, L.M.A., Smeenk, F.W.J.M., Schayck, C.P. van,Litsenburg, W. van, Janssen, A., Vliet, M. van, Seezink, W., Demunck,D.R.A.J., Pas, B. van de, Bruijn, P.J. de, Pouw, A. van der, Retera,J.M.A.M., Laat-Bierings, P. de, Eijsden, L. van, Braken, M., Eijsermans,R. & Rutten - van Mölken, M.P.M.H. (2010). Effectiveness and costeffectivenessof early assisted discharge for Chronic ObstructivePumonary Disease exacerbations: the design of a randomisedcontrolled trial. BMC Public Health, 10(618), 1-12.Uyl-de Groot, C.A., Senft, A., Bree, R. de, Leemans, R. & Hoekstra, O.S.(2010). Chest CT and Whole-Body 18F-FDG PET Are Cost-Effective inScreening for Distant Metastases in Head and Neck Cancer Patients.Journal of Nuclear Medicine, 51(2), 176-182.Uyl-de Groot, C.A., Groot, S. de & Steenhoek, A. (2010). The economicsof improved cancer survival rates: better outcomes, higher costs. Ex pertreview of pharmacoeconomics & outcomes research, 10(3), 283-292.Vehmeijer, J.T., Christiaans, I., Langen, I.M. van, Birnie, E., Bonsel, G.J.,Smets, E.M.A. & Wilde, A.A.M. (2009). Risk stratification for suddencardiac death in hypertrophic cardiomyopathy: Dutch cardiologists andthe care of mutation carriers. Netherlands Heart Journal, 17(12), 464-469.Vemer, P. & Rutten-van Mölken, M.P.M.H. (2010). Crossing Borders:Factors Affecting Differences in Cost-Effectiveness of SmokingCessation Interventions between European Countries. Value in Health,13(2), 230-241.Vemer, P., Rutten-van Mölken, M.P.M.H., Kaper, J., Hoogenveen, R.T.,Schayck, C.P. van & Feenstra, T.L. (2010). If you try to stop smoking,should we pay for it? The cost-utility of reimbursing smoking cessationsupport in the Netherlands. Addiction, 105, 1088-1097.Verhoef, T.I., Redekop, W.K., Darba, J., Geitona, M., Hughes, D.A.,Siebert, U., Boer, A. de & Maitland-van der Zee, A.H. (2010). Asystematic review of cost-effectiveness analyses of pharmacogeneticguideddosing in treatment with coumarin derivates.Pharmacogenomics, 11(7), 989-1002.81
Page 1:
Institute of Health Policy & Manage
Page 4 and 5:
COLOPHONActivities report 2009-2010
Page 6 and 7:
1Ambitious andcommittedProf. Wilfri
Page 8 and 9:
- expressed in the CWTS score - is
Page 10 and 11:
2ResearchProf. Erik Schut, PhD, dir
Page 12 and 13:
health care domain in developing co
Page 14 and 15:
Competition and regulationin health
Page 16 and 17:
Research theme 1The introduction of
Page 18 and 19:
Quality and efficiencyin health car
Page 20 and 21:
Since its foundation in 1982, socio
Page 22 and 23:
Management and organisationof healt
Page 24:
INFORMATION AND COMMUNICATION TECHN
Page 27 and 28:
esources and costs. This standardis
Page 29 and 30:
Part of the HEFPA projectis, for ex
Page 31 and 32: also see organisationssuch as Kaise
Page 33 and 34: countries and Panama.Whereas in Eur
Page 35 and 36: health care organisations. Managers
Page 37 and 38: example, the education facilitating
Page 39 and 40: This project will continuein 2011 u
Page 41 and 42: Management. In 2009Trudie van Duin
Page 43 and 44: students graduating isgood, but the
Page 45 and 46: Course was organised forthe third t
Page 47 and 48: Since 2009, the Academyprovides yea
Page 49 and 50: developments in thecompensation sys
Page 51 and 52: knowledge. Apart from the office ro
Page 54 and 55: 5Facts and figuresEducation2008-200
Page 56 and 57: 6StaffxxxRESEARCH GROUP HEALTH ECON
Page 58 and 59: xxxRESEARCH GROUP HEALTHINSURANCERe
Page 61 and 62: 7 AcademicPublicationsPlease turn t
Page 63 and 64: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
Page 65 and 66: Exter, A.P. den (2010). Health Syst
Page 67 and 68: Hermans, H.E.G.M. & Buijsen, M.A.J.
Page 69 and 70: Noord, T.J.C. van (2010). Gezondhei
Page 71 and 72: Al, M.J., Hakkaart-van Roijen, L.,
Page 73 and 74: Boormans, E.M.A., Birnie, E., Oepke
Page 75 and 76: Dror, D.M., Putten, O. van & Koren,
Page 77 and 78: Hakkaart-van Roijen, L., Verboom, P
Page 79 and 80: Kippersluis, J.L.W. van, O'Donnell,
Page 81: Poel, E. van de & Speybroeck, N. (2
Page 85 and 86: Wyers, C.E., Breedveld, J.J.L., Rei
Page 87 and 88: Zuiderent, T. & Berg, M. (2010). Th
Page 89 and 90: Thunnissen, M.M., Duivenvoorden, H.
Page 91 and 92: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
Page 93 and 94: Hasman, A., Andersen, S.K., Klein,
Page 95 and 96: Pirnejad, H. (2009). Invited commen
Page 97 and 98: Wijngaarden, J.D.H. van, Weggelaar-
Page 99 and 100: Hout, E. van, Stibane, R., Frederik
Page 101 and 102: Stoopendaal, A.M.V. (2009). De zorg
Page 103 and 104: WORKING PAPERSWORKING PAPERSAttema,
show all

Management

Create successful ePaper yourself

Delete template?

Save as template?